Alnylam Pharmaceuticals has appointed Akshay Vaishnaw to the newly created position of chief medical officer.
Vaishnaw was previously senior vice president of clinical research at Alnylam. Before that, he was senior director of translational medicine at Biogen Idec.
Mirna Therapeutics has appointed Art Krieg as a scientific advisor.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
